AACR Sponsored Listening Session with FDA
The American Association for Cancer Research (AACR) and the U.S. Food and Drug Administration (FDA) recorded a listening session on May 27, 2020 for patient advocates to learn more about cancer clinical trials during COVID-19. The session is about 45 minutes, with the pediatric questions at about minute 25.5, minute 37, and minute 41.
Categories
- Blog Posts (95)
- Explainer Post (12)
- Guest Blogs (16)
- Member Blogs (39)
- Survivorship Matters Blog (9)
- CAC2 News (25)
- Collaborative Achievements (14)
- Community News (253)
- In Memoriam (2)
- News Digest (204)
- Webinars (64)
Tags
Advocacy (55)
Annual Summit (7)
Appropriations (1)
Awareness (26)
AYA (2)
Bereavement (1)
Best Practices (14)
Biorepositories (2)
CAC2 News (9)
CAC2 Project Incubator (1)
CAC2 Projects (11)
Call to Action (25)
Call to Action Prevention (1)
Care Giving (1)
Clinical Trials (11)
COG (2)
Collaboration (14)
Data (15)
Delayed Diagnosis (2)
Digest (12)
Drug Development (12)
Drug Development collaboration (1)
Drug Shortages (2)
Ethics (1)
Family Support (16)
FDA (2)
Funding Research (7)
Genomics (6)
Global News (4)
Industry Perspective (5)
Member Access (12)
NCI (3)
Nutrition (2)
Post-Mortem Tissue Donation (1)
Prevention (4)
Psychosocial Support (6)
Rare and Ultra Rare Cancer (1)
Regulations (3)
Research (36)
Research Data (2)
Research Tissue Donation (1)
Social Work (1)
state advocacy (1)
Survivorship (28)
Venture Philanthropy (3)
Recent Posts
- CAC2 Childhood Cancer Community News Digest (November 26-December 1)
- CAC2 Childhood Cancer Community News Digest (November 18-25)
- Guest Blog–Conversations on Cancer – Pediatric Cancers: Navigating the Challenges Together
- Reflections from International Cancer Week 2024: A Renewed Commitment to the Fight Against Cancer
- CAC2 Childhood Cancer Community News Digest (November 11-17)